These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 8387881

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.
    Johnson DH, Bass D, Einhorn LH, Crawford J, Perez CA, Bartolucci A, Omura GA, Greco FA.
    J Clin Oncol; 1993 Jul; 11(7):1223-9. PubMed ID: 8391064
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
    Ihde DC, Mulshine JL, Kramer BS, Steinberg SM, Linnoila RI, Gazdar AF, Edison M, Phelps RM, Lesar M, Phares JC.
    J Clin Oncol; 1994 Oct; 12(10):2022-34. PubMed ID: 7931470
    [Abstract] [Full Text] [Related]

  • 25. Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study.
    Wampler GL, Heim WJ, Ellison NM, Ahlgren JD, Fryer JG.
    J Clin Oncol; 1991 Aug; 9(8):1438-45. PubMed ID: 1649265
    [Abstract] [Full Text] [Related]

  • 26. Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study.
    Livingston RB, Schulman S, Mira JG, Harker G, Vogel S, Coltman CA, Rivkin SE, Budd GT, Grever MR, Crowley JP.
    Cancer Treat Rep; 1986 Dec; 70(12):1395-401. PubMed ID: 3024826
    [Abstract] [Full Text] [Related]

  • 27. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC, Palmer M, Kinney B, Belch A, Hewitt J, Hanson J.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):337-42. PubMed ID: 9457818
    [Abstract] [Full Text] [Related]

  • 28. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.
    Roth BJ, Johnson DH, Einhorn LH, Schacter LP, Cherng NC, Cohen HJ, Crawford J, Randolph JA, Goodlow JL, Broun GO.
    J Clin Oncol; 1992 Feb 15; 10(2):282-91. PubMed ID: 1310103
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
    Komaki R, Shin DM, Glisson BS, Fossella FV, Murphy WK, Garden AS, Oswald MJ, Hong WK, Roth JA, Peters LJ.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):807-11. PubMed ID: 7860392
    [Abstract] [Full Text] [Related]

  • 31. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
    Collins C, Higano CS, Livingston RB, Griffin BR, Keppen MD, Miller TP.
    Cancer Chemother Pharmacol; 1989 Feb 15; 24(2):128-32. PubMed ID: 2543513
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA, Bacchi M, Hürny C, Bernhard J, Cerny T, Martinelli G, Leyvraz S, Senn HJ, Stahel R, Siegenthaler P.
    Ann Oncol; 1995 Feb 15; 6(2):157-66. PubMed ID: 7786823
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
    Shepherd FA, Evans WK, MacCormick R, Feld R, Yau JC.
    Cancer Treat Rep; 1987 Oct 15; 71(10):941-4. PubMed ID: 2820571
    [Abstract] [Full Text] [Related]

  • 36. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000 Oct 15; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 37. A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
    Tabata M, Kiura K, Okimoto N, Segawa Y, Shinkai T, Yonei T, Kuyama S, Harita S, Hotta K, Ueoka H, Tanimoto M.
    Cancer Chemother Pharmacol; 2007 Jun 15; 60(1):1-6. PubMed ID: 17393168
    [Abstract] [Full Text] [Related]

  • 38. [Chemotherapy for small cell lung cancer].
    Fukuoka M, Takada M, Masuda N, Furuse K, Saijo N, Ikegami H, Nishiwaki Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec 15; 31 Suppl():225-31. PubMed ID: 7516450
    [Abstract] [Full Text] [Related]

  • 39. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.
    Murray N, Shah A, Brown E, Kostashuk E, Laukkanen E, Goldie J, Band P, Van den Hoek J, Murphy K, Sparling T.
    Semin Oncol; 1986 Sep 15; 13(3 Suppl 3):24-30. PubMed ID: 3020695
    [Abstract] [Full Text] [Related]

  • 40. New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen.
    Westeel V, Murray N, Gelmon K, Shah A, Sheehan F, McKenzie M, Wong F, Morris J, Grafton C, Tsang V, Goddard K, Murphy K, Parsons C, Amy R, Page R.
    J Clin Oncol; 1998 May 15; 16(5):1940-7. PubMed ID: 9586913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.